K56 20mg Oxycodone Hydrochloride — K56 Pill Information (Tegrity Pharma)

Tegrity Pharma provides this comprehensive, safety‑first informational profile of the K56 20mg tablet of oxycodone hydrochloride. This page is intended to help patients, caregivers, and healthcare professionals identify the K56 Pill, understand its clinical role, recognize risks and side effects, and access trusted patient and professional resources. This content is educational and does not facilitate purchase, distribution, or medical advice.

Product Snapshot

Primary search phrases K56 20mg; Oxycodone hydrochloride 20mg; K56 Pill

Formulation context Immediate release or extended‑release formulations may exist; confirm formulation and strength with a licensed pharmacist.

Purpose of this page Pill identification, clinical context, safety guidance, and links to patient and professional resources provided by Tegrity Pharma.

Quick K56 20mg Identification Guide

Imprint K56

Strength 20 mg (as referenced)

Active ingredient Oxycodone hydrochloride

Typical appearance Tablet color and shape vary by manufacturer; imprint is a primary identifier but not definitive for strength or formulation.

Why accurate identification matters

• Prevent accidental misuse of different strengths.

• Detect counterfeit or substituted pills that may contain unknown substances.

• Ensure correct clinical decisions by prescribers and pharmacists.

How Tegrity Pharma helps

• Informational pill descriptions and verification checklists.

• Guidance to consult licensed pharmacists for definitive identification.

• Educational resources on safe handling and disposal.

K56 Pill Clinical Profile and Intended Use

Mechanism of action

Oxycodone hydrochloride is an opioid analgesic that binds to mu‑opioid receptors in the central nervous system to reduce the perception of pain and increase pain tolerance.

Indications

• Management of moderate to severe acute pain when short‑term opioid therapy is appropriate.

• Treatment of chronic pain in carefully selected patients when alternative therapies are inadequate and continuous opioid therapy is required.

Formulation differences

• Immediate‑release oxycodone provides rapid onset for breakthrough pain and requires more frequent dosing.

• Extended‑release formulations are designed for around‑the‑clock pain control and are not intended for as‑needed use.

• Important: Confirm whether a K56 tablet is immediate‑release or extended‑release with a pharmacist or prescriber before use.

Safety Profile and Common Side Effects

Common side effects

• Drowsiness and sedation

• Constipation and gastrointestinal discomfort

• Nausea and dizziness

Serious risks

• Respiratory depression, which can be life threatening at high doses or when combined with alcohol or sedatives

• Physical dependence and addiction with prolonged use

• Overdose risk if tablets are altered, misused, or combined with other depressants

Tegrity Pharma safety emphasis

• Clear warnings about never crushing or altering tablets unless explicitly instructed by a prescriber.

• Guidance on recognizing overdose signs and when to seek emergency care.

• Information on naloxone as an emergency reversal agent and how to discuss its availability with a clinician.

Interactions and Contraindications

Notable interactions

• Benzodiazepines and other sedatives increase the risk of respiratory depression.

• Alcohol potentiates opioid effects and increases overdose risk.

• Certain antidepressants and antipsychotics may interact and require monitoring.

Contraindications and cautions

• Known hypersensitivity to oxycodone or formulation components.

• Severe respiratory depression or acute asthma in unmonitored settings.

• Use caution in patients with head injury, increased intracranial pressure, severe hepatic impairment, or substance use disorder.

20 mg oxycodone Safe Use Guidelines 

Follow prescriber instructions exactly

• Take tablets whole; do not crush, chew, or dissolve controlled‑release forms.

• Maintain scheduled dosing intervals as directed.

Storage and security

• Store in a locked container out of reach of children and pets.

• Avoid leaving medication in shared or visible areas.

Disposal

• Use authorized medication take‑back programs when available.

• If take‑back is not accessible, follow local pharmacy guidance for safe disposal.

When to seek help

• Signs of overdose: slowed or stopped breathing, extreme drowsiness, inability to wake, pinpoint pupils.

• Allergic reactions: rash, swelling, difficulty breathing.

• Any unexpected or severe side effects should prompt immediate medical attention.

Alternatives and Multimodal Pain Management

Non‑opioid pharmacologic options

• NSAIDs (ibuprofen, naproxen) for inflammatory pain.

• Acetaminophen for mild to moderate pain.

• Adjuvant agents such as certain antidepressants or anticonvulsants for neuropathic pain.

Non‑pharmacologic strategies

• Physical therapy and structured exercise programs.

• Cognitive behavioral therapy and pain coping strategies.

• Interventional procedures such as nerve blocks when clinically appropriate.

• Lifestyle measures including sleep hygiene, nutrition, and stress management.

Multimodal approach

Combining pharmacologic and non‑pharmacologic strategies often reduces opioid requirements and improves functional outcomes.

Patient Resources on Tegrity Pharma

Oxycodone drug information

• Plain‑language summaries explaining how oxycodone works, expected effects, and safety precautions.

• Downloadable checklists for verifying prescriptions, safe storage, and disposal.

• Step‑by‑step guides on what to do if a dose is missed or if adverse effects occur.

Support and counseling

• Information on accessing pharmacist consultations, pain management programs, and behavioral health resources.

• Guidance on naloxone education and local availability.

Practical tools

• Pill identification checklists and visual guides (informational only).

• Printable medication logs to track dosing and side effects.

• Links to local take‑back programs and disposal instructions.

Professional Resources Linked by Tegrity Pharma

Clinical monographs and regulatory guidance

• Oxycodone monograph for prescribers and pharmacists outlining pharmacology, dosing, and monitoring.

• FDA resources on oxycodone formulations, capsules, and extended‑release tablets for regulatory and safety information.

• Clinical decision support tools for assessing opioid tolerance, calculating equianalgesic dosing, and developing tapering plans.

Best practice guidance

• Risk assessment frameworks for opioid prescribing.

• Monitoring strategies including urine drug testing, prescription drug monitoring program checks, and functional outcome assessments.

Other Brands and Related Products Featured in Tegrity Pharma Resources

Other brands associated with oxycodone

• OxyContin

• Roxicodone

• Xtampza ER

• RoxyBond

• Oxaydo

Related Treatment Guides on Tegrity Pharma

20 mg oxycodone for Chronic Pain

Evidence‑based approaches to long‑term pain management, including medication strategies, rehabilitation, and psychosocial interventions.

Oxycodone 20mg For Back Pain

Stepwise treatment options from conservative care to interventional procedures, emphasizing function and risk mitigation.

Pain

General resources on pain assessment, multimodal therapy, and safe medication use.

Frequently Asked Questions

What does K56 mean on a pill

K56 is an imprint used to identify certain oxycodone tablets. Imprints help confirm identity but should not be the sole method to determine strength or formulation.

Is K56 20mg the same as Oxycodone hydrochloride 20mg

K56 20mg refers to a tablet imprint associated with oxycodone hydrochloride at a 20 mg strength. Always confirm the formulation and dosing with a pharmacist or prescriber.

Can I split or crush K56 tablets

Do not split, crush, or alter tablets unless explicitly instructed by a prescriber. Altering tablets can release the full dose at once and increase the risk of overdose.

How long does a 20 mg oxycodone dose last

Duration depends on whether the formulation is immediate‑release or extended‑release, individual metabolism, and clinical factors. Immediate‑release typically lasts a few hours while extended‑release formulations are designed for longer intervals.

What should I do if I suspect counterfeit medication

Do not take the pill. Keep the packaging and pill, and consult a licensed pharmacist or prescriber immediately.

Patient Education Checklist

• Confirm the pill imprint and prescription label match.

• Understand dosing schedule and what to do if a dose is missed.

• Know signs of overdose and when to seek emergency care.

• Store medication securely and plan for safe disposal.

• Discuss alternatives and a tapering plan with your prescriber if long‑term use is anticipated.

How to Use This Information

This page is intended to inform and prepare patients and caregivers for safe conversations with healthcare professionals. Use it to verify pill identity, understand the clinical role of oxycodone hydrochloride, and learn about safety practices and alternatives. It is not a substitute for professional medical advice.

Tegrity Pharma encourages users to consult licensed healthcare professionals for personalized guidance and to use the resources linked on this page for further reading.

Legal and Safety Notice

This content is informational only and does not constitute medical advice, diagnosis, or treatment. Controlled substances such as oxycodone require a valid prescription and medical supervision. If you have questions about your medication, contact a licensed healthcare professional or pharmacist.

Closing Summary

The K56 20mg tablet of oxycodone hydrochloride is a medication that requires careful identification, informed clinical use, and strict adherence to safety practices. Tegrity Pharma provides patient and professional resources to support safe medication management, pill identification, and multimodal approaches to pain. Use these resources to guide conversations with clinicians and to make informed, safety‑focused decisions about pain treatment.